These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37308869)

  • 1. An integrated model for prognosis in vulvar squamous cell carcinoma.
    Zhang T; Zhu Y; Luo J; Li J; Niu S; Chen H; Zhou F
    BMC Cancer; 2023 Jun; 23(1):534. PubMed ID: 37308869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
    McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
    Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
    Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
    Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer.
    Carreras-Dieguez N; Saco A; Del Pino M; Pumarola C; Del Campo RL; Manzotti C; Garcia A; Marimon L; Diaz-Mercedes S; Fuste P; Rodrigo-Calvo MT; Vega N; Torné A; Rakislova N
    Histopathology; 2023 Apr; 82(5):731-744. PubMed ID: 36593525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering PD-L1 and CD8
    Chen J; Gu P; Wu H
    Biomed Res Int; 2020; 2020():8164365. PubMed ID: 32884946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?
    Alonso I; Fusté V; del Pino M; Castillo P; Torné A; Fusté P; Rios J; Pahisa J; Balasch J; Ordi J
    Gynecol Oncol; 2011 Sep; 122(3):509-14. PubMed ID: 21652058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.
    Kortekaas KE; Santegoets SJ; Tas L; Ehsan I; Charoentong P; van Doorn HC; van Poelgeest MIE; Mustafa DAM; van der Burg SH
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
    Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
    Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3 Expression in HPV-associated and HPV-independent Vulvar Squamous Cell Carcinomas: Patterns of Expression and Prognostic Significance.
    Vaziri Fard E; Zare SY; Fadare O
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):661-667. PubMed ID: 37779309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Yasumatsu R; Kuga R; Nozaki Y; Hashimoto K; Matsuo M; Wakasaki T; Tamae A; Taguchi K; Toh S; Masuda M; Nakagawa T; Oda Y
    Mod Pathol; 2021 Nov; 34(11):1966-1978. PubMed ID: 34218257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis.
    Qin Y; Luan J; Zhou X; Li Y
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33704390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva.
    Czogalla B; Pham D; Trillsch F; Rottmann M; Gallwas J; Burges A; Mahner S; Kirchner T; Jeschke U; Mayr D; Schmoeckel E
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):569-577. PubMed ID: 32025868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Expression in HPV-associated Versus HPV-independent Invasive Vulvar Squamous Cell Carcinoma.
    Bui CM; Medeiros F; Azimpouran M; Venturina M; Balzer B
    Int J Gynecol Pathol; 2024 Jul; 43(4):405-413. PubMed ID: 38303111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.